rs869320680
Variant names:
Variant summary
Our verdict is Likely pathogenic. The variant received 7 ACMG points: 7P and 0B. PVS1_StrongPM2PP5
The NM_004393.6(DAG1):c.743delC(p.Ala248GlufsTer19) variant causes a frameshift change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Pathogenic (no stars).
Frequency
Genomes: not found (cov: 32)
Consequence
DAG1
NM_004393.6 frameshift
NM_004393.6 frameshift
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 7.91
Publications
0 publications found
Genes affected
DAG1 (HGNC:2666): (dystroglycan 1) This gene encodes dystroglycan, a central component of dystrophin-glycoprotein complex that links the extracellular matrix and the cytoskeleton in the skeletal muscle. The encoded preproprotein undergoes O- and N-glycosylation, and proteolytic processing to generate alpha and beta subunits. Certain mutations in this gene are known to cause distinct forms of muscular dystrophy. Alternative splicing results in multiple transcript variants, all encoding the same protein. [provided by RefSeq, Nov 2015]
DAG1 Gene-Disease associations (from GenCC):
- autosomal recessive limb-girdle muscular dystrophy type 2PInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Genomics England PanelApp, G2P
- muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A9Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P
- neuromuscular disease caused by qualitative or quantitative defects of alpha-dystroglycanInheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
- muscular dystrophy-dystroglycanopathy, type AInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- isolated asymptomatic elevation of creatine phosphokinaseInheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Likely_pathogenic. The variant received 7 ACMG points.
PVS1
Loss of function variant, product does not undergo nonsense mediated mRNA decay. Variant is located in the 3'-most exon, not predicted to undergo nonsense mediated mRNA decay. There are 11 pathogenic variants in the truncated region.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 3-49531253-GC-G is Pathogenic according to our data. Variant chr3-49531253-GC-G is described in ClinVar as Pathogenic. ClinVar VariationId is 208543.Status of the report is no_assertion_criteria_provided, 0 stars.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_004393.6. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Sel. | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| DAG1 | MANE Select | c.743delC | p.Ala248GlufsTer19 | frameshift | Exon 3 of 3 | NP_004384.5 | Q14118 | ||
| DAG1 | c.743delC | p.Ala248GlufsTer19 | frameshift | Exon 6 of 6 | NP_001159400.3 | Q14118 | |||
| DAG1 | c.743delC | p.Ala248GlufsTer19 | frameshift | Exon 6 of 6 | NP_001171105.2 | Q14118 |
Ensembl Transcripts
| Sel. | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| DAG1 | TSL:1 MANE Select | c.743delC | p.Ala248GlufsTer19 | frameshift | Exon 3 of 3 | ENSP00000312435.2 | Q14118 | ||
| DAG1 | TSL:3 | c.743delC | p.Ala248GlufsTer19 | frameshift | Exon 4 of 4 | ENSP00000405859.2 | Q14118 | ||
| DAG1 | TSL:4 | c.743delC | p.Ala248GlufsTer19 | frameshift | Exon 3 of 3 | ENSP00000412067.2 | Q14118 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 genomes
Cov.:
32
GnomAD4 exome Cov.: 33
GnomAD4 exome
Cov.:
33
GnomAD4 genome Cov.: 32
GnomAD4 genome
Cov.:
32
ClinVar
ClinVar submissions
View on ClinVar Significance:Pathogenic
Revision:no assertion criteria provided
Pathogenic
VUS
Benign
Condition
1
-
-
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A9 (1)
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.